These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 22585859

  • 1. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
    Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C.
    Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
    [Abstract] [Full Text] [Related]

  • 2. Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated death.
    Verbrugge I, Johnstone RW.
    Cancer Discov; 2012 Feb; 2(2):112-4. PubMed ID: 22585854
    [Abstract] [Full Text] [Related]

  • 3. miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.
    Guo T, Zhang Y, Qu X, Che X, Li C, Fan Y, Wan X, Ma R, Hou K, Zhou H, He X, Hu X, Liu Y, Xu L.
    Cell Biol Int; 2018 May; 42(5):506-514. PubMed ID: 29274253
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.
    Zhang H, Huang C, Wang Y, Lu Z, Zhuang N, Zhao D, He J, Shi L.
    PLoS One; 2015 May; 10(5):e0127329. PubMed ID: 25993287
    [Abstract] [Full Text] [Related]

  • 5. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    Bellail AC, Tse MC, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C.
    J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
    [Abstract] [Full Text] [Related]

  • 6. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A, Crane CA, Weng C, Feletti A, Fang S, Parsa AT, Pieper RO.
    Cancer Res; 2010 Jun 15; 70(12):5046-53. PubMed ID: 20484045
    [Abstract] [Full Text] [Related]

  • 7. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A, Crane CA, Weng C, Feletti A, Parsa AT, Pieper RO.
    Cancer Res; 2009 Oct 15; 69(20):7911-6. PubMed ID: 19808964
    [Abstract] [Full Text] [Related]

  • 8. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
    Dong B, Lv G, Wang Q, Wei F, Bellail AC, Hao C, Wang G.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):433-8. PubMed ID: 22285182
    [Abstract] [Full Text] [Related]

  • 9. The Cellular Apoptosis Susceptibility Protein (CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation.
    Monian P, Jiang X.
    J Biol Chem; 2016 Jan 29; 291(5):2379-88. PubMed ID: 26668314
    [Abstract] [Full Text] [Related]

  • 10. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.
    Woo SM, Kwon TK.
    BMB Rep; 2019 Feb 29; 52(2):119-126. PubMed ID: 30638181
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.
    Qi L, Bellail AC, Rossi MR, Zhang Z, Pang H, Hunter S, Cohen C, Moreno CS, Olson JJ, Li S, Hao C.
    Apoptosis; 2011 Nov 29; 16(11):1150-64. PubMed ID: 21877214
    [Abstract] [Full Text] [Related]

  • 12. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L, Zhang Y, Qu X, Che X, Guo T, Li C, Ma R, Fan Y, Ma Y, Hou K, Li D, Hu X, Liu B, Yu R, Yan H, Gong J, Liu Y.
    Mol Oncol; 2017 Dec 29; 11(12):1733-1751. PubMed ID: 28972304
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C.
    Cell Signal; 2007 Nov 29; 19(11):2237-46. PubMed ID: 17693058
    [Abstract] [Full Text] [Related]

  • 14. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH, Bellail A, Tse MC, Yong VW, Hao C.
    J Neurosci; 2006 Mar 22; 26(12):3299-308. PubMed ID: 16554480
    [Abstract] [Full Text] [Related]

  • 15. The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis.
    Holloway J, Seeley A, Cobbe N, Turkington RC, Longley DB, Evergren E.
    Cell Death Dis; 2024 Jan 12; 15(1):40. PubMed ID: 38216558
    [Abstract] [Full Text] [Related]

  • 16. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8.
    Li Y, Kong Y, Zhou Z, Chen H, Wang Z, Hsieh YC, Zhao D, Zhi X, Huang J, Zhang J, Li H, Chen C.
    Cell Death Dis; 2013 Nov 28; 4(11):e935. PubMed ID: 24287696
    [Abstract] [Full Text] [Related]

  • 17. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Sun J, Yu X, Wang C, Yu C, Li Z, Nie W, Xu X, Miao X, Jin X.
    Med Sci Monit; 2017 Mar 08; 23():1190-1199. PubMed ID: 28270653
    [Abstract] [Full Text] [Related]

  • 18. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM, Hao C.
    Cancer Res; 2007 Jul 15; 67(14):6946-55. PubMed ID: 17638906
    [Abstract] [Full Text] [Related]

  • 19. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.
    J Biol Chem; 2003 Nov 07; 278(45):44338-47. PubMed ID: 12920112
    [Abstract] [Full Text] [Related]

  • 20. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
    Lu TT, Onizawa M, Hammer GE, Turer EE, Yin Q, Damko E, Agelidis A, Shifrin N, Advincula R, Barrera J, Malynn BA, Wu H, Ma A.
    Immunity; 2013 May 23; 38(5):896-905. PubMed ID: 23602765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.